Generalization of Neoantigen-Based Tumor Vaccine by Delivering Peptide-MHC Complex via Oncolytic Virus

Investigators provided a powerful approach to enhance the universality and efficacy of neoantigen vaccines, meeting the urgent need for universal neoantigen vaccines in the clinic to facilitate the further development of tumor immunotherapy.